Antithymocyte-globulin/ciclosporinNo response: 7 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1888卷 / 1期

关键词：

D O I：

10.1007/s40278-022-08413-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：71 / 71

相关论文

共 50 条

[21] Antithymocyte-globulin/ciclosporinReversible cerebral vasoconstriction syndrome (first report with antithymocyte-globulin): case report
Reactions Weekly, 2019, 1741 (1) : 41 - 41
[22] Antithymocyte-globulin/cyclophosphamide/danazol/fludarabineVarious toxicities: 3 case reports
Reactions Weekly, 2017, 1678 (1) : 28 - 28
[23] Antithymocyte-globulin/ciclosporin/methylprednisoloneNo therapeutic response: case report
Reactions Weekly, 2024, 2039 (1) : 73 - 73
[24] Antithymocyte-globulin/basiliximabHepatitis-B virus reactivation: 6 case reports
Reactions Weekly, 2022, 1917 (1) : 90 - 90
[25] Antithymocyte-globulin/basiliximab/rituximabPneumonia, sepsis and lack of efficacy: 4 case reports
Reactions Weekly, 2022, 1907 (1) : 73 - 73
[26] Antithymocyte-globulin/cyclophosphamide/tacrolimusFever, haemorrhagic cystitis and nephrotoxicity: 2 case reports
Reactions Weekly, 2020, 1799 (1) : 78 - 78
[27] Antithymocyte-globulin/mycophenolate-mofetil/tacrolimusDrug ineffective: 2 case reports
Reactions Weekly, 2024, 2036 (1) : 57 - 57
[28] Antithymocyte-globulin/tacrolimusLack of efficacy: case report
Reactions Weekly, 2023, 1976 (1) : 46 - 46
[29] Antithymocyte-globulin/cyclophosphamide/fludarabineDeath: case report
Reactions Weekly, 2017, 1641 (1) : 37 - 37
[30] Antithymocyte-globulin/carbamazepineVarious toxicities: case report
Reactions Weekly, 2020, 1807 (1) : 31 - 31

← 1 2 3 4 5 →